MedPage Today on MSN

Risky Drugs Still in the Mix for Dementia Patients

CNS-active drugs are associated with an increased risk of falls, delirium, and hospitalization. They are often prescribed for ...
The American Journal of Managed Care

Streamlining Lymphoma Care With Multi-Indication Bispecifics

While multi-indication bispecific therapies are likely to expand in lymphoma, their use must remain driven by efficacy, with ...
Business Insider

Medigene Announces Indication Selection for the Clinical Development of its Lead 3rd Generation TCR-T Therapy Program in Solid Tumors

Gastric cancer, ovarian cancer, myxoid/round cell liposarcoma and synovial sarcoma selected as initial clinical indications for lead program MDG1015 MDG1015 is a first-in-class, third generation TCR-T ...
Seeking Alpha

Longeveron® Presents Lomecel-B™ Data for Alzheimer’s Disease Indication in Late Breaking Poster Presentation at the Clinical Trials on Alzheimer’s Disease Conference ...

Findings offer potential mechanistic and clinical insights in the development of cellular therapy Lomecel-B™ for mild Alzheimer’s disease (AD) Lomecel-B™ capacity to inhibit MMP14 correlates with ...
Nasdaq

Tourmaline Bio Unveils Clinical Progress and New Indication

Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks Tourmaline Bio ( (TRML)) just ...
The Manila Times

Palvella Therapeutics Provides Corporate Update and 2026 Outlook: Advancing a Late Clinical-Stage Pipeline and Platform to Address Multiple Serious, Rare Skin Disease…

Phase 3 SELVA study evaluating QTORIN™ rapamycin 3.9% anhydrous gel (QTORIN™ rapamycin) for microcystic lymphatic ...
unr.edu

110. FDA Research Involving Investigational Drugs

Investigators and IRBs must ensure that research (i.e., clinical investigation) involving investigational drugs or biologics is conducted in accordance with applicable federal regulations. These ...